美国 · SEC FORM 4
Vera Therapeutics, Inc.
VERA · Nasdaq · CIK 0001831828 · Healthcare · Biotechnology
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
25 同一窗口内观察到的 Form 4 交易行
18 sales · 7 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2025-12-11 · ENRIGHT PATRICK G · $250.0K
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出High
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Fordyce MarshallPRESIDENT AND CEO
○▼▼○▼▼○▼▼○▼○▼
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR
○
Boman Nancy LeeChief Regulatory Officer
○
● 买入▼ 卖出○ 其他
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-12-11 · ENRIGHT PATRICK G.
近期 Form 4 活动
1买入
33卖出
20其他 Form 4 交易行
33SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出18 sale line(s) · 仅供背景
其他7 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 17,240,397
- 上期报告
- 17,035,040
- 日均成交量
- 2,212,016
- 回补天数
- 7.8
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-12-11 | ENRIGHT PATRICK G | 买入 (P) | Class A Common Stock | 5,882 | USD 42.50 | USD 249,985 | SEC 申报 ↗ |
| 2025-06-24 | ENRIGHT PATRICK G | 买入 (P) | Class A Common Stock | 40,607 | USD 22.35 | USD 907,566 | SEC 申报 ↗ |
| 2025-06-23 | ENRIGHT PATRICK G | 买入 (P) | Class A Common Stock | 209,393 | USD 20.87 | USD 4,370,032 | SEC 申报 ↗ |
| 2024-01-30 | Katabi Maha | 买入 (P) | Class A Common Stock | 161,290 | USD 31.00 | USD 4,999,990 | SEC 申报 ↗ |
| 2023-06-23 | Grant Sean | 买入 (P) | Class A Common Stock | 5,000 | USD 16.60 | USD 83,000 | SEC 申报 ↗ |
| 2023-06-20 | COMMODORE CAPITAL LP | 买入 (P) | Class A Common Stock | 448,217 | USD 15.17 | USD 6,799,452 | SEC 申报 ↗ |
| 2023-03-30 | SEIDENBERG BETH C | 买入 (P) | Class A Common Stock | 2,300 | USD 7.24 | USD 16,652 | SEC 申报 ↗ |
| 2023-03-28 | SEIDENBERG BETH C | 买入 (P) | Class A Common Stock | 23,908 | USD 7.24 | USD 173,094 | SEC 申报 ↗ |
| 2023-03-27 | SEIDENBERG BETH C | 买入 (P) | Class A Common Stock | 1,633 | USD 7.24 | USD 11,823 | SEC 申报 ↗ |
| 2023-03-24 | SEIDENBERG BETH C | 买入 (P) | Class A Common Stock | 1,833 | USD 7.24 | USD 13,271 | SEC 申报 ↗ |
| 2023-03-20 | SEIDENBERG BETH C | 买入 (P) | Class A Common Stock | 15,252 | USD 7.21 | USD 109,967 | SEC 申报 ↗ |
| 2023-03-17 | SEIDENBERG BETH C | 买入 (P) | Class A Common Stock | 74,045 | USD 7.12 | USD 527,200 | SEC 申报 ↗ |
| 2023-03-16 | SEIDENBERG BETH C | 买入 (P) | Class A Common Stock | 60,097 | USD 7.09 | USD 426,088 | SEC 申报 ↗ |
| 2023-03-15 | SEIDENBERG BETH C | 买入 (P) | Class A Common Stock | 32,844 | USD 7.12 | USD 233,849 | SEC 申报 ↗ |
| 2023-03-10 | SEIDENBERG BETH C | 买入 (P) | Class A Common Stock | 48,003 | USD 7.16 | USD 343,701 | SEC 申报 ↗ |
Form 4 申报证据
54 transaction lines in the latest 365-day window; 388 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Fordyce Marshall | 卖出 (S) | Class A Common Stock | 18,500 | USD 37.00 | USD 684,500 | SEC 申报 ↗ |
| 2026-09-15 | Fordyce Marshall | 期权行权／转换 (M) | Class A Common Stock | 18,500 | USD 2.90 | USD 53,650 | SEC 申报 ↗ |
| 2026-09-11 | Young Joseph R | 期权行权／转换 (M) | Class A Common Stock | 5,000 | USD 3.94 | USD 19,700 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Fordyce Marshall | 卖出 (S) | Class A Common Stock | 18,500 | USD 37.00 | USD 684,500 | SEC 申报 ↗ |
| 2026-09-15 | Fordyce Marshall | 期权行权／转换 (M) | Class A Common Stock | 18,500 | USD 2.90 | USD 53,650 | SEC 申报 ↗ |
| 2026-09-11 | Young Joseph R | 期权行权／转换 (M) | Class A Common Stock | 5,000 | USD 3.94 | USD 19,700 | SEC 申报 ↗ |
| 2026-09-02 | Fordyce Marshall | 卖出 (S) | Class A Common Stock | 18,500 | USD 35.12 | USD 649,720 | SEC 申报 ↗ |
| 2026-09-02 | Fordyce Marshall | 期权行权／转换 (M) | Class A Common Stock | 18,500 | USD 2.90 | USD 53,650 | SEC 申报 ↗ |
| 2026-08-03 | Boman Nancy Lee | 奖励／授予 (A) | Class A Common Stock | 44,987 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-07 | Fordyce Marshall | 卖出 (S) | Class A Common Stock | 46,250 | USD 42.29 | USD 1,956,086 | SEC 申报 ↗ |
| 2026-07-07 | Fordyce Marshall | 期权行权／转换 (M) | Class A Common Stock | 46,250 | USD 2.90 | USD 134,125 | SEC 申报 ↗ |
| 2026-07-07 | Fordyce Marshall | 卖出 (S) | Class A Common Stock | 46,250 | USD 42.29 | USD 1,956,086 | SEC 申报 ↗ |
| 2026-06-23 | Fordyce Marshall | 卖出 (S) | Class A Common Stock | 18,500 | USD 37.93 | USD 701,749 | SEC 申报 ↗ |
| 2026-06-23 | Fordyce Marshall | 期权行权／转换 (M) | Class A Common Stock | 18,500 | USD 2.90 | USD 53,650 | SEC 申报 ↗ |
| 2026-06-23 | Fordyce Marshall | 卖出 (S) | Class A Common Stock | 18,500 | USD 37.93 | USD 701,749 | SEC 申报 ↗ |
| 2026-05-12 | Fordyce Marshall | 卖出 (S) | Class A Common Stock | 18,500 | USD 36.74 | USD 679,766 | SEC 申报 ↗ |
| 2026-05-12 | Fordyce Marshall | 期权行权／转换 (M) | Class A Common Stock | 18,500 | USD 2.90 | USD 53,650 | SEC 申报 ↗ |
| 2026-05-12 | Fordyce Marshall | 卖出 (S) | Class A Common Stock | 18,500 | USD 36.74 | USD 679,766 | SEC 申报 ↗ |
| 2026-04-14 | Fordyce Marshall | 卖出 (S) | Class A Common Stock | 22,951 | USD 44.05 | USD 1,010,993 | SEC 申报 ↗ |
| 2026-03-23 | Wright-Mitchell Jane | 奖励／授予 (A) | Class A Common Stock | 42,403 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-13 | Young Joseph R | 期权行权／转换 (M) | Class A Common Stock | 10,000 | USD 3.94 | USD 39,400 | SEC 申报 ↗ |
| 2026-02-23 | Young Joseph R | 卖出 (S) | Class A Common Stock | 3,117 | USD 41.98 | USD 130,852 | SEC 申报 ↗ |
| 2026-02-23 | Turner William D. | 卖出 (S) | Class A Common Stock | 2,187 | USD 41.98 | USD 91,810 | SEC 申报 ↗ |
| 2026-02-23 | Skelton Laurence Matthew | 卖出 (S) | Class A Common Stock | 1,582 | USD 41.98 | USD 66,412 | SEC 申报 ↗ |
| 2026-02-23 | JOHNSON DAVID LEE | 卖出 (S) | Class A Common Stock | 2,579 | USD 41.98 | USD 108,266 | SEC 申报 ↗ |
| 2026-02-23 | Grant Sean | 卖出 (S) | Class A Common Stock | 4,949 | USD 41.98 | USD 207,759 | SEC 申报 ↗ |
| 2026-02-23 | Fordyce Marshall | 卖出 (S) | Class A Common Stock | 16,925 | USD 41.98 | USD 710,512 | SEC 申报 ↗ |
| 2026-02-23 | Brenner Robert | 卖出 (S) | Class A Common Stock | 2,151 | USD 41.98 | USD 90,299 | SEC 申报 ↗ |
| 2026-02-04 | Young Joseph R | 奖励／授予 (A) | Class A Common Stock | 10,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-04 | Turner William D. | 奖励／授予 (A) | Class A Common Stock | 25,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-04 | Skelton Laurence Matthew | 奖励／授予 (A) | Class A Common Stock | 20,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-04 | JOHNSON DAVID LEE | 奖励／授予 (A) | Class A Common Stock | 20,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-04 | Grant Sean | 奖励／授予 (A) | Class A Common Stock | 25,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | VERA |
| CIK | 0001831828 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 388 transaction lines from 2021-05-17 to 2026-09-15 48 P purchase lines · 188 S sale lines · 152 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.